New Analyses on Terbinafine Susceptibility and Mycological Cure Outcomes with MOB-015 Published in Journal of Fungi – Moberg Pharma
Moberg Pharma AB announced the publication of new analyses demonstrating potent antifungal activity of terbinafine against dermatophytes causing onychomycosis. Importantly, mycological cure with Mob-015 was achieved across the… read more.
